Rheumatic immune-related adverse events, An Issue of Rheumatic Disease Clinics of North America

Pre-existing Autoimmune Diseases and Immune Checkpoint Inhibitors for Cancer Treatment: Considerations About Initiation, Flares, Immune-Related Adverse Events, and Cancer Progression
Mimickers of Immune Checkpoint Inhibitor-induced Inflammatory Arthritis
The Utility of Laboratory Investigations for the Assessment and Management of Rheumatic Immune Related Adverse Events
The Current and Future of Biomarkers of Immune Related Adverse Events
Immunotherapy Toxicity Management in Clinical Practice: Building the Clinical Infrastructure for Immune-related Adverse Event Evaluation and Care
Patient Voices in Rheumatic Immune-related Adverse Events
Immune Checkpoint Inhibitor-induced Polymyalgia Rheumatica
Immune Checkpoint Inhibitor-induced Inflammatory Arthritis: Current Approaches to Management
Immune Checkpoint Inhibitor-induced Myositis
Immune Checkpoint Inhibitor-induced Sicca Syndrome
De novo Connective Tissue Disorders as Immune-related Adverse Events
Imaging in Rheumatic Immune-related Adverse Events
The Need for Classification Criteria of Immune Checkpoint Inhibitor-induced inflammatory Arthritis: A Scoping Review
Impact of Non-steroidal Anti-inflammatory Drugs, Glucocorticoids, and Disease[1]Modifying Anti-Rheumatic Drugs on Cancer Response to Immune Checkpoint Inhibitor Therapy